The market for launching new pharmaceutical and biotech products is crowded, competitive and data-driven. To hit the ground running and scale growth, pharma companies need a powerful analytics core. Yet many overlook an essential step to building analytics that sustain growth in the years that follow launch: mapping the organization’s long-term analytics, data and system needs.
